TTrialPathMatch Me to Trials
← Back to trials
RecruitingOpioid Use DisorderIntimate Partner Violence (IPV)Post Traumatic Stress Disorder PTSD

Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery

Eligible age

18+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Using a hybrid type 1 effectiveness-implementation approach, this study aims to evaluate the impact of a novel stepped care model ("PCT+2HOPE") versus treatment as usual (TAU) on increasing retention in community-based medication for opioid use disorder (MOUD) treatment among women who have experienced intimate partner violence (W-IPV). PCT+2HOPE includes Present-Centered Therapy (PCT+) with stepped care as indicated by moderate, severe, or extreme PTSD-related impairment in psychosocial functioning to Helping to Overcome PTSD through Empowerment (HOPE), two evidence-based behavioral interventions adapted for women with opioid use disorder (OUD). We will examine the effectiveness of PCT+2HOPE vs. TAU on the primary outcome (i.e., retention in MOUD treatment) and secondary outcomes related to trauma (i.e., PTSD-related impairment in psychosocial functioning and depression), substance use (i.e. OUD symptom severity, extra-medical opioid use \[i.e., use of prescription opioids without a doctor's prescription; in greater amounts, more often, longer than prescribed, or for a reason other than a doctor said they should be used\], and recovery), and empowerment. We will explore the extent to which the effectiveness of PCT+2HOPE vs. treatment as usual differs based on access to basic needs. We will also conduct an implementation-focused process evaluation.

Sponsor: Yale University

You may qualify if…

  • ✓ Woman;
  • ✓ Are ≥ 18 years old;
  • ✓ Receive MOUD treatment at one of the participating sites;
  • ✓ Have received MOUD for \>14 days to allow for initial stabilization;
  • ✓ Have initiated the current treatment episode within the past 12 months;
  • ✓ Experienced physical or psychological IPV in their lifetime;
  • ✓ Have at least moderate impairment in psychosocial functioning (on B-IPF) as a result of PTSD symptoms;
  • ✓ Available during the date/time of the intervention group

You may not qualify if…

  • ✕ Fail a capacity-to-consent questionnaire;
  • ✕ Have an unstable medical condition (e.g., hospitalization, planned surgery, newly starting chemotherapy, plans for palliative care) and/or unstable psychiatric illness (e.g., untreated psychosis) that would interfere with their ability to participate in study activities;
  • ✕ Will be unavailable for \>4 consecutive weeks during the study period (e.g., anticipated move, planned surgery);
  • ✕ Are unable to read/understand English;
  • ✕ Inability to provide at least one form of contact

Where it's recruiting

Connecticut

Bridgeport · Enfield · West Haven

Source: ClinicalTrials.gov · NCT07115030 · last updated 2026-07-16

Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engag · TrialPath